GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	35.16B +508.6%
Revenue (ttm)	3.62B +2.8%
Net Income	194.18M +31.1%
EPS	2.33 +38.8%
Shares Out	83.51M
PE Ratio	181.07
Forward PE	n/a
Dividend	0.75 (0.18%)
Ex-Dividend Date	Nov 24, 2026

Volume	1,056,422
Open	440.00
Previous Close	440.00
Day's Range	420.00 - 447.00
52-Week Range	55.10 - 609.00
Beta	0.30
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 16, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 14, 2026

Data Sources Report a data error